Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial - Concepedia

Concepedia

Publication | Open Access

Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial

DOI Full Paper Access

122

Citations

26

References

2013

Year

Kim Brixen, Roland Chapurlat, Angela M. Cheung, Tony M. Keaveny, Thomas Fuerst, Klaus Engelke, Robert R. Recker, Bernard J. Dardzinski, Nadia Verbruggen, Shabana Ather,

The Journal of Clinical Endocrinology & Metabolism

Abstract

Over 2 years, odanacatib decreased bone resorption, maintained bone formation, increased areal and volumetric BMD, and increased estimated bone strength at both the hip and spine.

References

	Year	Citations

Page 1